Skip to main content
Back to main menu

About Us

How we work

See what triggers an intervention and how supply and logistics allow our teams to respond quickly.

Learn more
How we're run

Discover our governance and what it means to be an association. Find a quick visual guide to our offices around the world.

Learn more
Reports and financials

Read through our annual financial and activity reports, and find out about where our funds come from and how they are spent.

Learn more
Accountability

Read the policies, reports, and plans on how we address issues like racism and reduce our carbon footprint, ensuring our actions align with the highest ethical standards.

Learn more

What we do

Médecins Sans Frontières brings medical humanitarian assistance to victims of conflict, natural disasters, epidemics or healthcare exclusion.

View all topics Activities by country
Featured Gaza Israel war Conflict in Sudan Surgery & trauma care

Where we work

In more than 70 countries, Médecins Sans Frontières provides medical humanitarian assistance to save lives and ease the suffering of people in crisis situations.

View all countries
Featured Palestine Sudan South Sudan

MSF Websites

A Global Network
Our offices around the world
Our offices around the world
Other Sites
View Resource Centre
Access Campaign

We set up the MSF Access Campaign in 1999 to push for access to, and the development of, life-saving and life-prolonging medicines, diagnostic tests and vaccines for people in our programmes and beyond.

GO TO SITE
CRASH

Based in Paris, CRASH conducts and directs studies and analysis of MSF actions. They participate in internal training sessions and assessment missions in the field.

GO TO SITE
UREPH

Based in Geneva, UREPH (or Research Unit) aims to improve the way MSF projects are implemented in the field and to participate in critical thinking on humanitarian and medical action.

GO TO SITE
ARHP

Based in Barcelona, ARHP documents and reflects on the operational challenges and dilemmas faced by the MSF field teams.

GO TO SITE
MSF Analysis

Based in Brussels, MSF Analysis intends to stimulate reflection and debate on humanitarian topics organised around the themes of migration, refugees, aid access, health policy and the environment in which aid operates.

GO TO SITE
MSF Supply

This logistical and supply centre in Brussels provides storage of and delivers medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
MSF Logistique

This supply and logistics centre in Bordeaux, France, provides warehousing and delivery of medical equipment, logistics and drugs for international purchases for MSF missions.

GO TO SITE
Amsterdam Procurement Unit

This logistical centre in Amsterdam purchases, tests, and stores equipment including vehicles, communications material, power supplies, water-processing facilities and nutritional supplements.

GO TO SITE
Brazilian Medical Unit

BRAMU specialises in neglected tropical diseases, such as dengue and Chagas, and other infectious diseases. This medical unit is based in Rio de Janeiro, Brazil.

GO TO SITE
MSF Medical Guidelines

Our medical guidelines are based on scientific data collected from MSF’s experiences, the World Health Organization (WHO), other renowned international medical institutions, and medical and scientific journals.

GO TO SITE
Epicentre

Providing epidemiological expertise to underpin our operations, conducting research and training to support our goal of providing medical aid in areas where people are affected by conflict, epidemics, disasters, or excluded from health care.

GO TO SITE
Evaluation Units

Evaluation Units have been established in Vienna, Stockholm, and Paris, assessing the potential and limitations of medical humanitarian action, thereby enhancing the effectiveness of our medical humanitarian work.

GO TO SITE
LGBTQI+ Inclusion in Health Settings

MSF works with LGBTQI+ populations in many settings over the last 25-30 years. LGBTQI+ people face healthcare disparities with limited access to care and higher disease rates than the general population.

GO TO SITE
LUXOR

The Luxembourg Operational Research (LuxOR) unit coordinates field research projects and operational research training, and provides support for documentation activities and routine data collection.

GO TO SITE
MSF Academy for Healthcare

To upskill and provide training to locally-hired MSF staff in several countries, MSF has created the MSF Academy for Healthcare.

GO TO SITE
Humanitarian Law

This Guide explains the terms, concepts, and rules of humanitarian law in accessible and reader-friendly alphabetical entries.

GO TO SITE
MSF Paediatric Days

The MSF Paediatric Days is an event for paediatric field staff, policy makers and academia to exchange ideas, align efforts, inspire and share frontline research to advance urgent paediatric issues of direct concern for the humanitarian field.

GO TO SITE
MSF Foundation

The MSF Foundation aims to create a fertile arena for logistics and medical knowledge-sharing to meet the needs of MSF and the humanitarian sector as a whole.

GO TO SITE
DNDi

A collaborative, patients’ needs-driven, non-profit drug research and development organisation that is developing new treatments for neglected diseases, founded in 2003 by seven organisations from around the world.

GO TO SITE
MSF Science Portal

Our digital portal dedicated to sharing the latest medical evidence from our humanitarian activities around the globe.

GO TO SITE
Noma

Noma is a preventable and treatable neglected disease, but 90 per cent of people will die within the first two weeks of infection if they do not receive treatment.

GO TO SITE
TIC

The TIC is aiming to change how MSF works to better meet the evolving needs of our patients.

GO TO SITE
Telemedicine

MSF's telemedicine hub aims to overcome geographic barriers for equitable, accessible, and quality patient care.

GO TO SITE
Sweden Innovation Unit

Launched in 2012, the MSF Sweden Innovation Unit deploys a human-centered approach for promoting a culture of innovation within MSF.

GO TO SITE
559 Results
 
msf-placeholder
Guatemala

New Guatemalan law and intellectual property provisions in DR-CAFTA threaten access to affordable medicines

The majority of patients in MSF's treatment programmes are prescribed generic ARVs, whereas Guatemala's social security system has spent 20 times more for some originator drugs. Press Release - 11 Mar 2005
 
msf-placeholder
HIV/AIDS

Global AIDS treatment efforts not on track

Since July 2004, only 260,000 new patients have benefited from ARV therapy in developing countries. Treatment expansion is moving at a snail's pace. From the perspective of a medical humanitarian organisation working in resource-poor countries to treat people with AIDS, the global picture is bleak. PEPFAR could be treating thousands more people with the funds it is spending. Press Release - 28 Jan 2005
 
msf-placeholder
HIV/AIDS

MSF and HIV/AIDS: Expanding treatment, facing new challenges

MSF has been caring for people living with HIV/AIDS since the mid-1990s. Project Update - 6 Dec 2004
 
msf-placeholder
HIV/AIDS

New 20 year patents threaten to end AIDS drugs for developing countries

"There are about five and a half million people in developing countries who need antiretroviral treatment now if they are to expect to survive two years," said Dr Gillies, international president of MSF. "Only about 440,000 are getting it." Project Update - 4 Dec 2004
 
msf-placeholder
HIV/AIDS

Access to AIDS care increasing at snail's pace

Overall, the AIDS pandemic remains undefeated. At today's briefing, MSF also highlighted the lack of paediatric formulations of antiretroviral medicines and the lack of reliable diagnostic tests to detect tuberculosis, the number one AIDS-related opportunistic infection, in HIV-positive individuals. Press Release - 1 Dec 2004
 
msf-placeholder
HIV/AIDS

Children with AIDS in developing countries die needlessly

MSF: further development of drugs and treatment for children needed. "There is a limited selection of ARVs available," says doctor Heather Culbert of the MSF team in Bukavu, in the east of the Democratic Republic of Congo (DRC). "The problem is that these are difficult to dose and to administer, especially to older children, which makes our work highly frustrating." Press Release - 1 Dec 2004
 
msf-placeholder
HIV/AIDS

World AIDS Day 2004 - Expanding treatment - Lessons learned so far

The number of patients treated with ARVs in MSF projects has increased rapidly. Today, MSF treats 150% more patients than in December 2003. Project Update - 1 Dec 2004
 
msf-placeholder
HIV/AIDS

World AIDS Day 2004: Beating the pandemic

Much of today's research into HIV/AIDS diagnostic and treatment tools is still targeted at developed country patients attending fully equipped, modern clinics. Yet the vast majority of patients living with HIV/AIDS live in developing countries. If we are to really extend the numbers of people accessing ARVs, priority must be given to research that focuses on the needs of patients in developing countries, and their specific conditions. Project Update - 1 Dec 2004
 
msf-placeholder
HIV/AIDS

The gap is growing: More resources needed now for neglected diseases

The pipeline of drugs for neglected diseases is virtually empty. From 1975 to 1999 of the 1393 new drugs marketed only 13, or a mere one per cent, were for tropical diseases. This imbalance is unacceptable in the second millennium.New drugs for neglected diseases: From pipeline to patients in PDF format. Press Release - 11 Nov 2004
 
msf-placeholder
Cambodia

Aids, the new killer in the fields

A nation still recovering from years of political bloodletting, Cambodia is being weakened by a new scourge. Project Update - 17 Oct 2004
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more